Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Telmisartan IP 40mg + Chlorthialidone 12.5 + Cilnidipine 10mg Tablets
Therapeutic Category
Hypertension/ Blood Pressure, Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Telbolife CLC 12.5 Tablet is a triple-combination antihypertensive formulation that includes Telmisartan 40mg (an angiotensin II receptor blocker), Chlorthalidone 12.5mg (a thiazide-like diuretic), and Cilnidipine 10mg (a calcium channel blocker). This synergistic combination targets high blood pressure through multiple mechanisms—relaxing blood vessels, reducing fluid retention, and improving blood flow—offering comprehensive and long-lasting blood pressure control.
Common side effects may include dizziness, fatigue, increased urination, electrolyte imbalance, headache, and swelling of the feet or hands. Rarely, hypotension or kidney-related side effects may occur.
Indicated for the management of essential hypertension, especially in patients whose blood pressure is not adequately controlled with dual therapy.
Regular monitoring of blood pressure, kidney function, and electrolytes is essential. This medication should be taken as prescribed, preferably at the same time each day. Not recommended during pregnancy or breastfeeding without medical supervision.
Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 1000mg Tablets
Composition : Dapagliflozin Propanediol Monohydrate 10mg + Vildagliptin I.P. 100mg Tablets
Composition : Metformin 1000mg (S.R.) Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Telmisartan 40mg + Cilnidipine 10mg + Chlorthalidone Tablet has strong demand in the cardiology, hypertension management, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cardiovascular care portfolios.
Medical distributors and agencies can benefit from consistent demand for hypertension management under medical supervision. Telmisartan 40mg is an angiotensin II receptor blocker (ARB) that helps lower blood pressure by relaxing blood vessels and reducing the effects of angiotensin II Cilnidipine 10mg is a calcium channel blocker that helps relax blood vessels and improve blood flow, contributing to effective blood pressure control Chlorthalidone is a thiazide-like diuretic that helps reduce excess fluid and sodium from the body, further supporting blood pressure reduction and cardiovascular risk management This triple-drug combination is commonly prescribed for the treatment of essential hypertension, particularly in patients whose blood pressure is not adequately controlled with single or dual-drug therapy, as advised by healthcare professionals Helps achieve sustained blood pressure control, thereby reducing the risk of stroke, heart attack, heart failure, and kidney complications associated with uncontrolled hypertension Oral tablet formulation supports once-daily dosing, improving patient convenience and long-term treatment adherence Requires regular monitoring of blood pressure, kidney function, serum electrolytes, and overall cardiovascular status during therapy Frequently utilized in cardiology clinics, general medicine practices, hypertension clinics, and hospitals Widely prescribed by cardiologists, nephrologists, and general physicians for long-term hypertension management This strengthens a comprehensive cardiovascular and antihypertensive portfolio. Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Telmisartan 40mg + Cilnidipine 10mg + Chlorthalidone Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from consistent prescription demand, expanding cardiovascular care market opportunities, long-term therapy requirements, reliable supply chain support, repeat business, and attractive margins in the antihypertensive segment.
Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality cardiovascular pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.